-
2023-507233-19-00
10
2023-02-16
Treatment of IgAN
-
2022-502140-13-00
6
2023-01-11
Atrial fibrillation
Acute coronary syndrome
Chronic coronary syndrome
-
2024-514328-18-00
7
2022-12-06
Spinocerebellar ataxia types 1, 3 and Huntington's disease
-
2023-507041-28-00
4
2022-11-28
Solid and Hematological Malignancies
-
2023-508389-13-00
5
2022-11-08
Combined endpoint of all-cause mortality, kidney failure, and hospital
-
2023-509462-38-00
11
2022-10-25
Patients with advanced cancer.
-
2024-511979-15-00
4
2022-10-14
relapsed/refractory Non-Hodgkin Lymphoma
-
2022-500745-24-00
10
2022-09-20
Salivary Duct Carcinoma
-
2023-507518-28-00
5
2022-09-13
Acute myeloid leukemia
-
2024-515528-35-00
11
2022-09-08
Congenital Haemophilia A
-
2023-503335-18-00
1
2022-07-29
Chronic myeloid leukemia
-
2024-513924-41-01
6
2022-05-11
Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).
-
2023-505220-57-03
5
2022-05-09
Predicted severe acute pancreatitis
-
2023-509743-27-00
4
2022-04-29
Systemic sclerosis associated with interstitial lung disease
-
2024-513797-22-00
5
2022-03-09
HER2 positive esophageal adenocarcinoma
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2023-505497-14-00
4
2021-12-09
Proteinuric glomerular diseases including:
•Focal segmental glomerulo
-
2023-507230-24-00
4
2021-02-17
Cervical cancer
-
2024-514010-12-00
1
2020-12-03
Advanced Malignancies
-
2023-508722-99-00
4
2020-11-19
Vulvar cancer
-
2024-510783-23-00
7
2020-10-29
Fallopian Tube Cancer
-
2024-512526-28-00
5
2020-10-28
Locally recurrent rectal cancer
-
2024-515625-29-00
5
2020-06-16
Apnea of prematurity
-
2023-509343-27-00
11
2019-10-28
C3 Glomerulopathy or idiopathic immune-complex membranoproliferative g